TCM effective in global defense against malaria

   2022-06-08 ecns0
核心提示:Comoros President Azali Assoumani said his country has benefited from the use of artemisinin-based treatment programs to fight malaria in re
Comoros President Azali Assoumani said his country has benefited from the use of artemisinin-based treatment programs to fight malaria in recent years.Assoumani thanked Chinese researchers for their foresight and generous help with regards to the treatment, making the remarks at the International Forum on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All, in late April.With help from China, Comoros has become one of the countries with the lowest incidences of malaria in East Africa, and from 2012 to 2020, the rate dropped from 9 per 1,000 to less than 5 per 1,000, according to Assoumani.Comoros is also one of the countries that has successfully blocked the local transmission chain of malaria, he said.South China's Guangdong province has spearheaded six campaigns aimed at the swift eradication of malaria in Southeast Asia, Africa and the South Pacific region since 2003, with remarkable results having been achieved, according to government officials.Guangdong, the birthplace of using artemisinin to fight malaria, has sent more than 260 technical experts abroad and helped train more than 10,000 local medical workers. The province has set up six overseas anti-malaria centers, said Xu Qingfeng, deputy director of the Guangdong Provincial Health Commission, who also heads the province's traditional Chinese medicine bureau.The overseas centers include the Sino-Africa Malaria Prevention and Treatment Center, the Sino-Comoros Malaria Prevention and Treatment Center, the Sino-Papua New Guinea Traditional Chinese Medicine Center, the Sino-Togo Traditional Chinese Medicine Center, the Sino-Malawi Traditional Chinese Medicine Center and the Sino-Malawi Artemisinin Research Center."The centers have played an important role in the fight against malaria worldwide in previous decades," Xu said at a recent briefing on the fight against malaria with artemisinin, held in Guangzhou, capital of Guangdong.With the help of Chinese doctors and the treatment of artemisinin, Cambodia has now been listed as a country at the pre-elimination of malaria stage recognized by the World Health Organization, Xu said.The national malaria incidence rate in Comoros has dropped by more than 98 percent, with a zero death rate from malaria having been achieved, he said.The first pilot area in Sao Tome and Principe has reported zero cases of malaria for eight consecutive months for the first time, while the malaria infection rate among the 45,000 people on the Kirivina Islands, the pilot area in Papua New Guinea, has decreased by more than 95 percent, with a zero malaria death rate having been achieved, according to Xu.According to official statistics, since the implementation of the artemisinin malaria elimination projects, more than 20 million people from malaria-hit nations and regions around the world have directly benefited from the diagnosis and treatment from doctors and medical experts, and the usage of artemisinin medicines from Guangdong, Xu said.Artemisinin, a drug that helped China eliminate malaria, is a gift of traditional Chinese medicine to people all over the world and Guangdong is not only the birthplace of using Artemisia annua, also known as sweet wormwood, the plant used to cure malaria patients, but also the pioneer of making an industry around Artemisia annua go international, said Xu.He said Guangdong has made remarkable achievements in promoting the cultivation and breeding of high-quality Artemisia annua varieties.The artemisinin content found in the province's Artemisia annua has increased from 0.5 percent to 2.97 percent, due to extensive research and development.An average of five kilograms of artemisinin can be extracted from a metric ton of Artemisia annua globally, but the figure reaches 12 kilograms from a ton of Artemisia annua planted in Fengshun county of Meizhou city in the eastern part of Guangdong, Xu said."The fourth generation of combination artemisinin-piperaquine tablets (ArtequickO), jointly developed and produced by Guangzhou University of Chinese Medicine and a local company, has obtained international patent protection in 40 countries, completed trademark registration in 36 countries, and has been listed and sold in 26 malaria endemic countries around the world."It's an innovative drug with completely independent intellectual property rights, and has many advantages, including high efficiency, quick effect, few side effects and simple application, he said."The tablets have now become the main antimalarial drugs in the free market of malaria highly endemic countries, including Nigeria, Tanzania and Kenya," he added.Song Jianping, director of the artemisinin research center at Guangzhou University of Chinese Medicine, said a representative of the WHO has also affirmed China's contribution to the fight against malaria."The successful implementation of the artemisinin compound malaria elimination demonstration project in the Sao Tome and Principe malaria demonstration area has opened up a new path for Sao Tome and Principe to eliminate malaria," he said.Malaria is a major infectious disease threatening the health of all mankind.According to the WHO's World Malaria Report 2021, more than 140 million malaria cases were reported worldwide in 2020, with 470,000 people dying of the disease, indicating malaria has become an important factor hindering the social and economic development of the world, especially in Africa.Comoros President Azali Assoumani said his country has benefited from the use of artemisinin-based treatment programs to fight malaria in recent years.Assoumani thanked Chinese researchers for their foresight and generous help with regards to the treatment, making the remarks at the International Forum on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All, in late April.With help from China, Comoros has become one of the countries with the lowest incidences of malaria in East Africa, and from 2012 to 2020, the rate dropped from 9 per 1,000 to less than 5 per 1,000, according to Assoumani.Comoros is also one of the countries that has successfully blocked the local transmission chain of malaria, he said.South China's Guangdong province has spearheaded six campaigns aimed at the swift eradication of malaria in Southeast Asia, Africa and the South Pacific region since 2003, with remarkable results having been achieved, according to government officials.Guangdong, the birthplace of using artemisinin to fight malaria, has sent more than 260 technical experts abroad and helped train more than 10,000 local medical workers. The province has set up six overseas anti-malaria centers, said Xu Qingfeng, deputy director of the Guangdong Provincial Health Commission, who also heads the province's traditional Chinese medicine bureau.The overseas centers include the Sino-Africa Malaria Prevention and Treatment Center, the Sino-Comoros Malaria Prevention and Treatment Center, the Sino-Papua New Guinea Traditional Chinese Medicine Center, the Sino-Togo Traditional Chinese Medicine Center, the Sino-Malawi Traditional Chinese Medicine Center and the Sino-Malawi Artemisinin Research Center."The centers have played an important role in the fight against malaria worldwide in previous decades," Xu said at a recent briefing on the fight against malaria with artemisinin, held in Guangzhou, capital of Guangdong.With the help of Chinese doctors and the treatment of artemisinin, Cambodia has now been listed as a country at the pre-elimination of malaria stage recognized by the World Health Organization, Xu said.The national malaria incidence rate in Comoros has dropped by more than 98 percent, with a zero death rate from malaria having been achieved, he said.The first pilot area in Sao Tome and Principe has reported zero cases of malaria for eight consecutive months for the first time, while the malaria infection rate among the 45,000 people on the Kirivina Islands, the pilot area in Papua New Guinea, has decreased by more than 95 percent, with a zero malaria death rate having been achieved, according to Xu.According to official statistics, since the implementation of the artemisinin malaria elimination projects, more than 20 million people from malaria-hit nations and regions around the world have directly benefited from the diagnosis and treatment from doctors and medical experts, and the usage of artemisinin medicines from Guangdong, Xu said.Artemisinin, a drug that helped China eliminate malaria, is a gift of traditional Chinese medicine to people all over the world and Guangdong is not only the birthplace of using Artemisia annua, also known as sweet wormwood, the plant used to cure malaria patients, but also the pioneer of making an industry around Artemisia annua go international, said Xu.He said Guangdong has made remarkable achievements in promoting the cultivation and breeding of high-quality Artemisia annua varieties.The artemisinin content found in the province's Artemisia annua has increased from 0.5 percent to 2.97 percent, due to extensive research and development.An average of five kilograms of artemisinin can be extracted from a metric ton of Artemisia annua globally, but the figure reaches 12 kilograms from a ton of Artemisia annua planted in Fengshun county of Meizhou city in the eastern part of Guangdong, Xu said."The fourth generation of combination artemisinin-piperaquine tablets (ArtequickO), jointly developed and produced by Guangzhou University of Chinese Medicine and a local company, has obtained international patent protection in 40 countries, completed trademark registration in 36 countries, and has been listed and sold in 26 malaria endemic countries around the world."It's an innovative drug with completely independent intellectual property rights, and has many advantages, including high efficiency, quick effect, few side effects and simple application, he said."The tablets have now become the main antimalarial drugs in the free market of malaria highly endemic countries, including Nigeria, Tanzania and Kenya," he added.Song Jianping, director of the artemisinin research center at Guangzhou University of Chinese Medicine, said a representative of the WHO has also affirmed China's contribution to the fight against malaria."The successful implementation of the artemisinin compound malaria elimination demonstration project in the Sao Tome and Principe malaria demonstration area has opened up a new path for Sao Tome and Principe to eliminate malaria," he said.Malaria is a major infectious disease threatening the health of all mankind.According to the WHO's World Malaria Report 2021, more than 140 million malaria cases were reported worldwide in 2020, with 470,000 people dying of the disease, indicating malaria has become an important factor hindering the social and economic development of the world, especially in Africa.
 
标签: Society
反对 0举报 0 评论 0
 

免责声明:本文仅代表作者个人观点,与好速译英语翻译(本网)无关。其原创性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
    本网站有部分内容均转载自其它媒体,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责,若因作品内容、知识产权、版权和其他问题,请及时提供相关证明等材料并与我们留言联系,本网站将在规定时间内给予删除等相关处理.

  • 贵州警方因袭击记者获刑 - Guizhou police puni
    根据联合调查组周四发布的消息,贵州省毕节市的三名警察因袭击并打伤一名记者而被拘留。其中一名袭击者姓熊,当时是织金县马场镇警察局副局长,而另外两名姓陶和姓李的人是公安局的辅警,新闻稿说。熊和陶已被行政拘留20天
    06-01 Society
  • 预计2027年建成第二条京沪高铁 - Second Beijin
    据江苏省交通运输局消息,国家发展和改革委员会最近批准了一份连接山东潍坊和江苏宿迁的高铁线路的可行性研究报告。潍坊至宿迁高铁全长399公里,共有12个车站。根据中国“十四五”铁路发展规划,这是连接华东城市的第二条京沪高速铁路的一段
    06-01 Society
  • 印度教授:人口变化不是中印之间的游戏 - India
    联合国今年的一份人口报告显示,印度可能已经超过中国,成为世界上人口最多的国家。然而,印度新德里贾瓦哈拉尔·尼赫鲁大学国际关系教授斯瓦兰·辛格表示,印度劳动力的增长并不一定意味着中国的增长轨迹会下降。他补充说,人口变化应该从客观的角度来考虑。辛格说,这里有三个方面值得一提。首先,demog
    06-01 Society
  • 上海迪士尼乐园将颁布货车禁令 - Shanghai Disn
    上海迪士尼度假区于5月31日宣布,从6月30日起,将禁止旅行车和其他类型的运载工具,包括大型婴儿车、推车、婴儿车行李箱和拖车。据度假区称,这项禁令是因为人们不断抱怨这些设备占用了度假区内的大量空间,那些有健康状况的人仍然可以使用最高速度为16的手动和电动轮椅
    06-01 Society
  • 青少年心理健康服务有待改善 - Youths' me
    周三,专家们呼吁培养更多的儿科精神科医生,提高家长和学校工作人员对心理健康问题的认识,以便更迅速地发现需要帮助的儿童。中日友好医院的精神科医生铁昌乐说,大约17.5%的6至16岁的在校儿童和青少年患有精神障碍,引用2021年发布的一项研究。精神疾病,如注意力缺陷多动障碍、焦虑症、对立
    06-01 Society
  • 降雨浸泡小麦后河南采取行动 - Henan takes act
    河南省是中国主要的小麦生产基地,该省正在采取全面措施,包括排干田地里的水、派遣收割机和加速谷物干燥,以抵消近期降雨对小麦成熟期的影响。这场降雨于上周中旬开始,持续了六天,社交媒体上发布的视频显示,这导致一些作物掉落,一些小麦发芽
    06-01 Society
  • 当局努力保护未成年人上网 - Authorities work
    在国际儿童节的前一天,检察官们在周三表示,随着新方案的出现,检察机关采取行动保护网络空间中的未成年人,他说,网络空间监管日趋复杂和严峻
    06-01 Society
  • GRE普通考试发生重大变化 - GRE general test m
    ETS周二宣布,从9月22日起,GRE普通考试将用不到两个小时的时间完成,大约是目前考试时间的一半。这一变化将使其成为顶尖专业、商学院和法学院录取考试中最短的考试。为了缩短考试时间,GRE将取消分析写作部分的“分析论点”任务,减少定量推理和口头推理部分的问题数量,并删除未评分部分
    06-01 Society
  • “老年友好型”车辆未来多云 - Future cloudy f
    在中国,无人驾驶的电动三轮车和四轮车一直很受老年人的欢迎。许多老年人使用“老人乐”,字面意思是“老人的快乐”,来做短途跑腿,比如接孙子放学和买杂货。他们喜欢使用低速车,因为它们易于驾驶和停车。这些车辆也不受适用于机动车辆的交通规则的约束,也不受非法停车罚单的约束
    05-31 Society
  • AD治疗Dupixent获准在中国使用 - AD treatment
    法国赛诺菲制药公司周二宣布,世界上第一种治疗特应性皮炎(AD)的靶向生物制剂Dupixent,已获中国国家药品监督管理局批准。该注射液将用于治疗6个月至6岁的婴儿和儿童的中重度AD。AD是一种常见的免疫炎症疾病,严重影响着全国数百万患者的健康和生活质量。疾病
    05-31 Society
点击排行